New approaches to understanding the immune response to vaccination and infection

Vaccine

Volumn 33, Issue 40, 2015, Pages 5271-5281

  Furman, David ^a   Davis, Mark M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Computational immunology; Elastic net; Feature selection; High throughput methods; Human immunology; Immune profiling; Regularization; Systems immunology; Vaccinology

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR; VACCINE;

ARTICLE; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INFECTION; METABOLISM; METABOLOMICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VACCINATION; ADAPTIVE IMMUNITY; BLOOD; GENOMICS; INNATE IMMUNITY; PROCEDURES; PROTEIN MICROARRAY; SYSTEMS BIOLOGY;

ADAPTIVE IMMUNITY; CYTOKINES; GENOMICS; HUMANS; IMMUNITY, INNATE; INFECTION; PROTEIN ARRAY ANALYSIS; SYSTEMS BIOLOGY; VACCINATION; VACCINES;

EID: 84941811337     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.117     Document Type: Article

References (154)

1. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
2. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.
3. Shen-Orr S.S., Furman D. Variability in the immune system: of vaccine responses and immune states. Curr Opin Immunol 2013, 25:542-547.
4. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.
5. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205:3119-3131.
6. Furman D., Jojic V., Kidd B., Shen-Orr S., Price J., Jarrell J., et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 2013, 9:659.
7. Davis M.M., Krogsgaard M., Huse M., Huppa J., Lillemeier B.F., Li Q.J. T cells as a self-referential, sensory organ. Annu Rev Immunol 2007, 25:681-695.
8. Irvine D.J., Purbhoo M.A., Krogsgaard M., Davis M.M. Direct observation of ligand recognition by T cells. Nature 2002, 419:845-849.
9. Purbhoo M.A., Irvine D.J., Huppa J.B., Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004, 5:524-530.
10. Huang J., Brameshuber M., Zeng X., Xie J., Li Q.J., Chien Y.H., et al. A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells. Immunity 2013, 39:846-857.
11. Jackson K.J., Liu Y., Roskin K.M., Glanville J., Hoh R.A., Seo K., et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 2014, 16:105-114.
12. Jiang N., He J., Weinstein J.A., Penland L., Sasaki S., He X.S., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013, 5:171ra19.
13. Vollmers C., Sit R.V., Weinstein J.A., Dekker C.L., Quake S.R. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc Natl Acad Sci U S A 2013, 110:13463-13468.
14. Robinson W.H. Sequencing the functional antibody repertoire-diagnostic and therapeutic discovery. Nat Rev Rheumatol 2015, 11(3):171-182. 10.1038/nrrheum.2014.220.
15. Han A., Glanville J., Hansmann L., Davis M.M. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol 2014, 32:684-692.
16. Heller M.J. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 2002, 4:129-153.
17. Bedognetti D., Wang E., Sertoli M.R., Marincola F.M. Gene-expression profiling in vaccine therapy and immunotherapy for cancer. Expert Rev Vaccines 2010, 9:555-565.
18. Parnell G., McLean A., Booth D., Huang S., Nalos M., Tang B. Aberrant cell cycle and apoptotic changes characterise severe influenza A infection - a meta-analysis of genomic signatures in circulating leukocytes. PLoS ONE 2011, 6:e17186.
19. Davenport E.E., Antrobus R.D., Lillie P.J., Gilbert S., Knight J.C. Transcriptomic profiling facilitates classification of response to influenza challenge. J Mol Med 2015, 93:105-114.
20. Parnell G.P., Tang B.M., Nalos M., Armstrong N.J., Huang S.J., Booth D.R., et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock 2013, 40:166-174.
21. Wynn J.L., Cvijanovich N.Z., Allen G.L., Thomas N.J., Freishtat R.J., Anas N., et al. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 2011, 17:1146-1156.
22. Zaas A.K., Chen M., Varkey J., Veldman T., Hero A.O., Lucas J., et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 2009, 6:207-217.
23. Ockenhouse C.F., Hu W.C., Kester K.E., Cummings J.F., Stewart A., Heppner D.G., et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun 2006, 74:5561-5573.
24. Kwissa M., Nakaya H.I., Onlamoon N., Wrammert J., Villinger F., Perng G.C., et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 2014, 16:115-127.
25. Geiss G.K., Bumgarner R.E., An M.C., Agy M.B., van 't Wout A.B., Hammersmark E., et al. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 2000, 266:8-16.
26. Ockenhouse C.F., Bernstein W.B., Wang Z., Vahey M.T. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J Infect Dis 2005, 191:2064-2074.
27. Bucasas K.L., Franco L.M., Shaw C.A., Bray M.S., Wells J.M., Nino D., et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis 2011, 203:921-929.
28. Henn A.D., Wu S., Qiu X., Ruda M., Stover M., Yang H., et al. High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature. Sci Rep 2013, 3:2327.
29. Furman D., Hejblum B.P., Simon N., Jojic V., Dekker C.L., Thiebaut R., et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A 2014, 111:869-874.
30. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011, 12:786-795.
31. Li S., Rouphael N., Duraisingham S., Romero-Steiner S., Presnell S., Davis C., et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014, 15:195-204.
32. Craig F.E., Foon K.A. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008, 111:3941-3967.
33. Jaso J.M., Wang S.A., Jorgensen J.L., Lin P. Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future. Bone Marrow Transpl 2014, 49:1129-1138.
34. Sutherland D.R., Anderson L., Keeney M., Nayar R., Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematotherapy 1996, 5:213-226.
35. Rebibou J.M., Carvalho Bittencourt M., Saint-Hillier Y., Chabod J., Dupont I., Chalopin J.M., et al. T-cell flow-cytometry cross-match: influence in renal transplantation. Transpl Proc 1998, 30:2800-2801.
36. Strohmeyer J.C., Blume C., Meisel C., Doecke W.D., Hummel M., Hoeflich C., et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytom B: Clin Cytom 2003, 53:54-62.
37. Barnett D., Walker B., Landay A., Denny T.N. CD4 immunophenotyping in HIV infection. Nat Rev Microbiol 2008, 6:S7-S15.
38. Martini C., Patroncini S., Mighetto L., Audino A., Girardi P., Giachino O., et al. Cytometry and rhesus: not only for haemolytic disease of the newborn. Blood Transfus 2011, 9:104-106.
39. O'Gorman M.R., Zollett J., Bensen N. Flow cytometry assays in primary immunodeficiency diseases. Methods Mol Biol 2011, 699:317-335.
40. Nicholson J.K. Use of flow cytometry in the evaluation and diagnosis of primary and secondary immunodeficiency diseases. Arch Pathol Lab Med 1989, 113:598-605.
41. Garratty G., Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995, 35:157-178.
42. Bolton D.L., Roederer M. Flow cytometry and the future of vaccine development. Expert Rev Vaccines 2009, 8:779-789.
43. Spearman P., Lally M.A., Elizaga M., Montefiori D., Tomaras G.D., McElrath M.J., et al. A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. J Infect Dis 2011, 203:1165-1173.
44. De Rosa S.C., Thomas E.P., Bui J., Huang Y., deCamp A., Morgan C., et al. HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. J Immunol 2011, 187:3391-3401.
45. Keefer M.C., Frey S.E., Elizaga M., Metch B., De Rosa S.C., Barroso P.F., et al. A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine 2011, 29:1948-1958.
46. Davis I.D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci U S A 2004, 101:10697-10702.
47. Buchbinder S.P., Mehrotra D.V., Duerr A., Fitzgerald D.W., Mogg R., Li D., et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008, 372:1881-1893.
48. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003, 281:65-78.
49. Maecker H.T. Multiparameter flow cytometry monitoring of T cell responses. Methods Mol Biol 2009, 485:375-391.
50. Mei H.E., Yoshida T., Sime W., Hiepe F., Thiele K., Manz R.A., et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009, 113:2461-2469.
51. Cox R.J., Brokstad K.A., Zuckerman M.A., Wood J.M., Haaheim L.R., Oxford J.S. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994, 12:993-999.
52. Moldoveanu Z., Clements M.L., Prince S.J., Murphy B.R., Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995, 13:1006-1012.
53. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
54. He X.S., Sasaki S., Narvaez C.F., Zhang C., Liu H., Woo J.C., et al. Plasmablast-derived polyclonal antibody response after influenza vaccination. J Immunol Methods 2011, 365:67-75.
55. Halliley J.L., Kyu S., Kobie J.J., Walsh E.E., Falsey A.R., Randall T.D., et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010, 28:3582-3587.
56. Odendahl M., Mei H., Hoyer B.F., Jacobi A.M., Hansen A., Muehlinghaus G., et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005, 105:1614-1621.
57. Lee F.E., Halliley J.L., Walsh E.E., Moscatiello A.P., Kmush B.L., Falsey A.R., et al. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol 2011, 186:5514-5521.
58. Balakrishnan T., Bela-Ong D.B., Toh Y.X., Flamand M., Devi S., Koh M.B., et al. Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS ONE 2011, 6:e29430.
59. Wrammert J., Onlamoon N., Akondy R.S., Perng G.C., Polsrila K., Chandele A., et al. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol 2012, 86:2911-2918.
60. Qiao S.W., Raki M., Gunnarsen K.S., Loset G.A., Lundin K.E., Sandlie I., et al. Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol 2011, 187:3064-3071.
61. Han A., Newell E.W., Glanville J., Fernandez-Becker N., Khosla C., Chien Y.H., et al. Dietary gluten triggers concomitant activation of CD4+ and CD8+ alphabeta T cells and gammadelta T cells in celiac disease. Proc Natl Acad Sci U S A 2013, 110:13073-13078.
62. Lee F.E., Falsey A.R., Halliley J.L., Sanz I., Walsh E.E. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis 2010, 202:1659-1666.
63. Bendall S.C., Simonds E.F., Qiu P., Amir el A.D., Krutzik P.O., Finck R., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
64. Newell E.W., Sigal N., Bendall S.C., Nolan G.P., Davis M.M. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 2012, 36:142-152.
65. Bodenmiller B., Zunder E.R., Finck R., Chen T.J., Savig E.S., Bruggner R.V., et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 2012, 30:858-867.
66. Behbehani G.K., Bendall S.C., Clutter M.R., Fantl W.J., Nolan G.P. Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry A 2012, 81:552-566.
67. Newell E.W., Sigal N., Nair N., Kidd B.A., Greenberg H.B., Davis M.M. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol 2013, 31:623-629.
68. Horowitz A., Strauss-Albee D.M., Leipold M., Kubo J., Nemat-Gorgani N., Dogan O.C., et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 2013, 5:208ra145.
69. Strauss-Albee D.M., Horowitz A., Parham P., Blish C.A. Coordinated regulation of NK receptor expression in the maturing human immune system. J Immunol 2014, 193:4871-4879.
70. Wolchinsky R., Hod-Marco M., Oved K., Shen-Orr S.S., Bendall S.C., Nolan G.P., et al. Antigen-dependent integration of opposing proximal TCR-signaling cascades determines the functional fate of T lymphocytes. J Immunol 2014, 192:2109-2119.
71. Swadling L., Capone S., Antrobus R.D., Brown A., Richardson R., Newell E.W., et al. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci Transl Med 2014, 6:261ra153.
72. Sen N., Mukherjee G., Sen A., Bendall S.C., Sung P., Nolan G.P., et al. Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Rep 2014, 8:633-645.
73. O'Gorman W.E., Huang H., Wei Y.L., Davis K.L., Leipold M.D., Bendall S.C., et al. The split virus influenza vaccine rapidly activates immune cells through Fcgamma receptors. Vaccine 2014, 32:5989-5997.
74. Krishnaswamy S., Spitzer M.H., Mingueneau M., Bendall S.C., Litvin O., Stone E., et al. Systems biology. Conditional density-based analysis of T cell signaling in single-cell data. Science 2014, 346:1250689.
75. Gaudilliere B., Fragiadakis G.K., Bruggner R.V., Nicolau M., Finck R., Tingle M., et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med 2014, 6:255ra131.
76. Fergusson J.R., Smith K.E., Fleming V.M., Rajoriya N., Newell E.W., Simmons R., et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 2014, 9:1075-1088.
77. Bendall S.C., Davis K.L., Amir el A.D., Tadmor M.D., Simonds E.F., Chen T.J., et al. Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell 2014, 157:714-725.
78. Brodin P., Jojic V., Gao T., Bhattacharya S., Angel C.J., Furman D., et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015, 160:37-47.
79. Yao Y., Liu R., Shin M.S., Trentalange M., Allore H., Nassar A., et al. CyTOF supports efficient detection of immune cell subsets from small samples. J Immunol Methods 2014, 415:1-5.
80. Metzker M.L. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46.
81. Quail M.A., Smith M., Coupland P., Otto T.D., Harris S.R., Connor T.R., et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 2012, 13:341.
82. Orru V., Steri M., Sole G., Sidore C., Virdis F., Dei M., et al. Genetic variants regulating immune cell levels in health and disease. Cell 2013, 155:242-256.
83. Cho P., Gelinas L., Corbett N.P., Tebbutt S.J., Turvey S.E., Fortuno E.S., et al. Association of common single-nucleotide polymorphisms in innate immune genes with differences in TLR-induced cytokine production in neonates. Genes Immun 2013, 14:199-211.
84. Wu X., Zhou T., Zhu J., Zhang B., Georgiev I., Wang C., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011, 333:1593-1602.
85. Laserson U., Vigneault F., Gadala-Maria D., Yaari G., Uduman M., Vander Heiden J.A., et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A 2014, 111:4928-4933.
86. Sherwood A.M., Desmarais C., Livingston R.J., Andriesen J., Haussler M., Carlson C.S., et al. Deep sequencing of the human TCRgamma and TCRbeta repertoires suggests that TCRbeta rearranges after alphabeta and gammadelta T cell commitment. Sci Transl Med 2011, 3:90ra61.
87. Wang C., Liu Y., Xu L.T., Jackson K.J., Roskin K.M., Pham T.D., et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 2014, 192:603-611.
88. Wu Y.C., Kipling D., Dunn-Walters D.K. Age-related changes in human peripheral blood IGH repertoire following vaccination. Front Immunol 2012, 3:193.
89. Shifrut E., Baruch K., Gal H., Ndifon W., Deczkowska A., Schwartz M., et al. CD4(+) T cell-receptor repertoire diversity is compromised in the spleen but not in the bone marrow of aged mice due to private and sporadic clonal expansions. Front Immunol 2013, 4:379.
90. Parameswaran P., Liu Y., Roskin K.M., Jackson K.K., Dixit V.P., Lee J.Y., et al. Convergent antibody signatures in human dengue. Cell Host Microbe 2013, 13:691-700.
91. Tan Y.C., Kongpachith S., Blum L.K., Ju C.H., Lahey L.J., Lu D.R., et al. Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis. Arthritis Rheumatol 2014, 66:2706-2715.
92. Buenrostro J.D., Giresi P.G., Zaba L.C., Chang H.Y., Greenleaf W.J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 2013, 10:1213-1218.
93. Poland G.A., Kennedy R.B., Ovsyannikova I.G. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. PLoS Pathog 2011, 7:e1002344.
94. Paweletz C.P., Charboneau L., Bichsel V.E., Simone N.L., Chen T., Gillespie J.W., et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20:1981-1989.
95. Nam M.J., Madoz-Gurpide J., Wang H., Lescure P., Schmalbach C.E., Zhao R., et al. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 2003, 3:2108-2115.
96. Robinson W.H., Fontoura P., Lee B.J., de Vegvar H.E., Tom J., Pedotti R., et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 2003, 21:1033-1039.
97. Gaze S., Driguez P., Pearson M.S., Mendes T., Doolan D.L., Trieu A., et al. An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog 2014, 10:e1004033.
98. Lu F., Li J., Wang B., Cheng Y., Kong D.H., Cui L., et al. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J Proteomics 2014, 102:66-82.
99. Lian G., Wei C., Wang D., Cui M., Wang Z., Liu X., et al. Protein profiling of Helicobacter pylori-associated gastric cancer. Am J Pathol 2014, 184:1343-1354.
100. Charles R.C., Liang L., Khanam F., Sayeed M.A., Hung C., Leung D.T., et al. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol 2014, 21:280-285.
101. Price J.V., Haddon D.J., Kemmer D., Delepine G., Mandelbaum G., Jarrell J.A., et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Investig 2013, 123:5135-5145.
102. Mendes T.A., Reis Cunha J.L., de Almeida Lourdes R., Rodrigues Luiz G.F., Lemos L.D., dos Santos A.R., et al. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays. PLoS Negl Trop Dis 2013, 7:e2524.
103. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 2005, 79:11724-11733.
104. Hermanson G., Chun S., Felgner J., Tan X., Pablo J., Nakajima-Sasaki R., et al. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax((R)) using proteome microarrays and development of recombinant protein ELISAs. Vaccine 2012, 30:614-625.
105. Cannella A.P., Lin J.C., Liang L., Atluri V., Gotuzzo E., Felgner P.L., et al. Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosis. J Clin Microbiol 2012, 50:922-926.
106. Suwannasaen D., Mahawantung J., Chaowagul W., Limmathurotsakul D., Felgner P.L., Davies H., et al. Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis. J Infect Dis 2011, 203:1002-1011.
107. Davies D.H., Molina D.M., Wrammert J., Miller J., Hirst S., Mu Y., et al. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 2007, 7:1678-1686.
108. Xiong X., Wang X., Wen B., Graves S., Stenos J. Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches. BMC Microbiol 2012, 12:35.
109. Vigil A., Chen C., Jain A., Nakajima-Sasaki R., Jasinskas A., Pablo J., et al. Profiling the humoral immune response of acute and chronic Q fever by protein microarray. Mol Cell Proteomics 2011, 10. M110 006304.
110. Maksimov P., Zerweck J., Maksimov A., Hotop A., Gross U., Pleyer U., et al. Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans. Clin Vaccine Immunol 2012, 19:865-874.
111. Stephenson K.E., Neubauer G.H., Reimer U., Pawlowski N., Knaute T., Zerweck J., et al. Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development. J Immunol Methods 2015, 416:105-123. 10.1016/j.jim.2014.11.006.
112. Legutki J.B., Magee D.M., Stafford P., Johnston S.A. A general method for characterization of humoral immunity induced by a vaccine or infection. Vaccine 2010, 28:4529-4537.
113. Price J.V., Jarrell J.A., Furman D., Kattah N.H., Newell E., Dekker C.L., et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS ONE 2013, 8:e64555.
114. Navalkar K.A., Johnston S.A., Woodbury N., Galgiani J.N., Magee D.M., Chicacz Z., et al. Application of immunosignatures for diagnosis of valley fever. Clin Vaccine Immunol 2014, 21:1169-1177.
115. da Silva F.R., Napoleao-Pego P., De-Simone S.G. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine. Vaccine 2014, 32:6251-6258.
116. Price J.V., Tangsombatvisit S., Xu G., Yu J., Levy D., Baechler E.C., et al. On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. Nat Med 2012, 18:1434-1440.
117. Garcia-Pineres A., Hildesheim A., Dodd L., Kemp T.J., Williams M., Harro C., et al. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles. Clin Vaccine Immunol 2007, 14:984-989.
118. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008, 8:86.
119. Anbarasu D., Raja C.P., Raja A. Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings. Cytokine 2013, 61:747-754.
120. Smith S.G., Lecher S., Blitz R., Locht C., Dockrell H.M. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012, 42:2511-2522.
121. Eriksson J.C., Cox R.J., Szyszko E., Davidsson A., Brokstad K.A. Local and systemic cytokine and chemokine responses after parenteral influenza vaccination. Influenza Other Respir Viruses 2007, 1:139-146.
122. Lalor M.K., Floyd S., Gorak-Stolinska P., Ben-Smith A., Weir R.E., Smith S.G., et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011, 204:1075-1085.
123. Yucesoy B., Johnson V.J., Fluharty K., Kashon M.L., Slaven J.E., Wilson N.W., et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009, 27:6991-6997.
124. James E.A., LaFond R.E., Gates T.J., Mai D.T., Malhotra U., Kwok W.W. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins. J Virol 2013, 87:12794-12804.
125. Lozupone C.A., Li M., Campbell T.B., Flores S.C., Linderman D., Gebert M.J., et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 2013, 14:329-339.
126. LaVoy E.C., Nieman D.C., Henson D.A., Shanely R.A., Knab A.M., Cialdella-Kam L., et al. Latent cytomegalovirus infection and innate immune function following a 75km cycling time trial. Eur J Appl Physiol 2013, 113:2629-2635.
127. Christian L.M., Porter K., Karlsson E., Schultz-Cherry S., Iams J.D. Serum proinflammatory cytokine responses to influenza virus vaccine among women during pregnancy versus non-pregnancy. Am J Reprod Immunol 2013, 70:45-53.
128. Andrade B.B., Hullsiek K.H., Boulware D.R., Rupert A., French M.A., Ruxrungtham K., et al. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis 2013, 207:1379-1388.
129. Caskey M., Lefebvre F., Filali-Mouhim A., Cameron M.J., Goulet J.P., Haddad E.K., et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011, 208:2357-2366.
130. Langley R.J., Tipper J.L., Bruse S., Baron R.M., Tsalik E.L., Huntley J., et al. Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med 2014, 190:445-455.
131. Roe B., Kensicki E., Mohney R., Hall W.W. Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS ONE 2011, 6:e23641.
132. Weiner J., Parida S.K., Maertzdorf J., Black G.F., Repsilber D., Telaar A., et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS ONE 2012, 7:e40221.
133. Galagan J.E., Minch K., Peterson M., Lyubetskaya A., Azizi E., Sweet L., et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 2013, 499:178-183.
134. Langley R.J., Tsalik E.L., van Velkinburgh J.C., Glickman S.W., Rice B.J., Wang C., et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med 2013, 5:195ra95.
135. Barnes V.M., Kennedy A.D., Panagakos F., Devizio W., Trivedi H.M., Jonsson T., et al. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PLOS ONE 2014, 9:e105181.
136. Seymour C.W., Yende S., Scott M.J., Pribis J., Mohney R.P., Bell L.N., et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med 2013, 39:1423-1434.
137. Fontaine K.A., Camarda R., Lagunoff M. Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol 2014, 88:4366-4374.
138. Oh J.Z., Ravindran R., Chassaing B., Carvalho F.A., Maddur M.S., Bower M., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014, 41:478-492.
139. Ravindran R., Khan N., Nakaya H.I., Li S., Loebbermann J., Maddur M.S., et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 2014, 343:313-317.
140. Donoho D.L., Johnstone I.M., Kerkiacharian G., Picard D. Wavelet shrinkage: asymptopia?. J R Stat Soc 1995, 57:301-369.
141. Chen S.S., Donoho D.L., Saunders M.A. Atomic decomposition by Basis Pursuit. SIAM Rev 2001, 43:129-159.
142. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc 1996, 58:267-288.
143. Efron B., Hastie T., Johnstone I., Tibshirani R. Least angle regression. Ann Stat 2004, 32:407-499.
144. Lin Y., Zhang H.H. Component selection and smoothing in multivariate nonparametric regression. Ann Stat 2006, 34:2272-2297.
145. Bach F.R. Bolasso model consistent Lasso estimation through the bootstrap. Proceedings of the 25th International Conference on Machine Learning 2008.
146. Zare H., Haffari G., Gupta A., Brinkman R.R. Scoring relevancy of features based on combinatorial analysis of Lasso with application to lymphoma diagnosis. BMC Genomics 2013, 14(Suppl. 1):S14.
147. Furman D. Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. Expert Rev. Vaccines 2015, 14:461-471.
148. Han D., Cai X., Wen J., Kenyon N.S., Chen Z. From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes. Front Immunol 2012, 3:320.
149. Shannon C.P., Balshaw R., Ng R.T., Wilson-McManus J.E., Keown P., McMaster R., et al. Two-stage, in silico deconvolution of the lymphocyte compartment of the peripheral whole blood transcriptome in the context of acute kidney allograft rejection. PLOS ONE 2014, 9:e95224.
150. Chen L., Schiffer J.M., Dalton S., Sabourin C.L., Niemuth N.A., Plikaytis B.D., et al. Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques. Clin Vaccine Immunol 2014, 21:1512-1520.
151. Srinivasan S., Hoffman N.G., Morgan M.T., Matsen F.A., Fiedler T.L., Hall R.W., et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 2012, 7:e37818.
152. Beck D., Foster J.A. Machine learning techniques accurately classify microbial communities by bacterial vaginosis characteristics. PLOS ONE 2014, 9:e87830.
153. Mansiaux Y., Carrat F. Detection of independent associations in a large epidemiologic dataset: a comparison of random forests, boosted regression trees, conventional and penalized logistic regression for identifying independent factors associated with H1N1pdm influenza infections. BMC Med Res Methodol 2014, 14:99.
154. Su L.F., Kidd B.A., Han A., Kotzin J.J., Davis M.M. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013, 38:373-383.